Black women with breast cancer may have worse outcomes than peers despite similar genetic recurrence scores

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainNon-Hispanic Black women with hormone receptor (HR)-positive/HER2-negative, lymph node-positive breast cancer had wors

Updated on: December 24,2023

Black women with breast cancer may have worse outcomes than peers despite similar genetic recurrence scores

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainNon-Hispanic Black women with hormone receptor (HR)-positive/HER2-negative, lymph node-positive breast cancer had wors

Updated on:December 24,2023

Researchers develop gel to deliver cancer drugs for solid tumors

byMass General BrighamCredit: Pixabay/CC0 Public DomainIntratumoral therapy—in which cancer drugs are injected directly into tumors—is a promising treatment option for solid cancers but has show

Updated on: January 03,2024

Researchers develop gel to deliver cancer drugs for solid tumors

byMass General BrighamCredit: Pixabay/CC0 Public DomainIntratumoral therapy—in which cancer drugs are injected directly into tumors—is a promising treatment option for solid cancers but has show

Updated on:January 03,2024

Study shows INT-1B3 inhibits distant tumor metastasis and significantly prolongs survival

by Impact Journals LLCProposed mode of action of INT-1B3/1B3.INT-1B3/1B3 induces apoptosis and cell death leading to expression of DAMPs, e.g., expression of calreticulin, reduced expression of CD39 a

Updated on: August 27,2024

Study shows INT-1B3 inhibits distant tumor metastasis and significantly prolongs survival

by Impact Journals LLCProposed mode of action of INT-1B3/1B3.INT-1B3/1B3 induces apoptosis and cell death leading to expression of DAMPs, e.g., expression of calreticulin, reduced expression of CD39 a

Updated on:August 27,2024

National quality improvement initiative successfully helps address pandemic-related cancer screening deficits

byAmerican College of SurgeonsMean Monthly Screening Test Volumes in April Through November. 2021 April and May 2021 is the preintervention period. Vertical dotted line indicates the start of th

Updated on: December 23,2023

National quality improvement initiative successfully helps address pandemic-related cancer screening deficits

byAmerican College of SurgeonsMean Monthly Screening Test Volumes in April Through November. 2021 April and May 2021 is the preintervention period. Vertical dotted line indicates the start of th

Updated on:December 23,2023

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

byThe Spanish National Cancer Research CentreSection of a mouse invasive mesothelioma tumour. Credit: CNIOExposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggr

Updated on: December 22,2023

Two drugs used in combination prove to be effective against most aggressive asbestos cancer in mice

byThe Spanish National Cancer Research CentreSection of a mouse invasive mesothelioma tumour. Credit: CNIOExposure to asbestos is the major risk factor for malignant mesothelioma, a type of aggr

Updated on:December 22,2023

Marijuana component offers opioid alternative by effectively treating dental pain

by Andrew Smith,Rutgers UniversityCBD reduced the dental pain and increased the bite force in patients presented with emergency toothache. (A) Median visual analog scale (VAS) pain scores per ti

Updated on: March 25,2024

Marijuana component offers opioid alternative by effectively treating dental pain

by Andrew Smith,Rutgers UniversityCBD reduced the dental pain and increased the bite force in patients presented with emergency toothache. (A) Median visual analog scale (VAS) pain scores per ti

Updated on:March 25,2024

Disruption of immune cells in blood is linked to cancer outcomes, new tool reveals

Updated on: April 29,2025

Disruption of immune cells in blood is linked to cancer outcomes, new tool reveals

Updated on:April 29,2025

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang

Updated on: December 25,2023

Identification of colony stimulating factor 1 receptor offers new strategy for cancer immunotherapy

by Zhang Nannan,Chinese Academy of SciencesIHMT-CSF1R-833 alters the macrophage polarization in M2 macrophages derived from RAW264.7 cells by inducing the M1 macrophage phenotype. Credit: Liang

Updated on:December 25,2023

How a little-known glycoprotein blocks a cancer cell's immune response

by University of MichiganThe interaction between STC1 and calreticulin. Credit: University of Michigan Rogel Cancer CenterIt was an unexpected discovery that started with an analysis of more than

Updated on: March 26,2024

How a little-known glycoprotein blocks a cancer cell's immune response

by University of MichiganThe interaction between STC1 and calreticulin. Credit: University of Michigan Rogel Cancer CenterIt was an unexpected discovery that started with an analysis of more than

Updated on:March 26,2024

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

byYale UniversityDFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by sevent

Updated on: December 28,2023

Clinical trial shows significant disease-free survival for patients diagnosed with non-small cell lung cancer

byYale UniversityDFS per investigator assessment. Kaplan-Meier estimates of duration of (A) DFS in patients with stage II-IIIA disease and (B) in the overall population (stage IB-IIIA) by sevent

Updated on:December 28,2023

For cancer, a biopharmaceutical company and UC San Diego test another kind of immune cell

by Bradley J. Fikes, The San Diego Union-TribuneWhen the U.S. Food and Drug Administration approved the first cell-based gene therapies for cancer in 2017, advanced malignancies once seen as terminal

Updated on: December 18,2023

For cancer, a biopharmaceutical company and UC San Diego test another kind of immune cell

by Bradley J. Fikes, The San Diego Union-TribuneWhen the U.S. Food and Drug Administration approved the first cell-based gene therapies for cancer in 2017, advanced malignancies once seen as terminal

Updated on:December 18,2023

Study shows promise of new anti-KRAS drug for pancreatic cancer

by Perelman School of Medicine at the University of PennsylvaniaMRTX1133 reduces metastatic burden in a tail vein model. (A) Representative brightfield images of lungs from vehicle and MRTX1133 (

Updated on: January 30,2024

Study shows promise of new anti-KRAS drug for pancreatic cancer

by Perelman School of Medicine at the University of PennsylvaniaMRTX1133 reduces metastatic burden in a tail vein model. (A) Representative brightfield images of lungs from vehicle and MRTX1133 (

Updated on:January 30,2024